Bioorganic and Medicinal Chemistry Letters p. 2307 - 2312 (1997)
Update date:2022-07-29
Topics:
Reiter, Lawrence A.
Melvin Jr., Lawrence S.
Crean, Geraldine L.
Showell, Henry J.
Koch, Kevin
Biggers, Michael S.
Cheng, John B.
Breslow, Robbin
Conklyn, Maryrose J.
Farrell, Cathy A.
Hada, William A.
Laird, Ellen R.
Martin, John J.
Miller, G. Todd
Pillar, Joanne S.
The SAR of a series of 7-chromanylacetic acids has been investigated with the aim of identifying potent and selective LTB4 receptor antagonists. We found optimal activity in derivatives with α,α-disubstitution on the acetic acid and a C-4 hydroxy group and a C-3 lipophilic group on the chromane ring. CP-105696 (43), which contains a 4-phenylbenzyl C-3 substituent, was selected for development.
View MoreShanghai Sinofluoro Scientific Co., Ltd
Contact:+86-21-64279360
Address:Room 1006,Building 3,#58 East Xinjian Road, Shanghai ,201100,China,
Shandong LuZhou Amino Acid Co., Ltd
Contact:86-539-2218025
Address:yishui economic and technical development zone zhenxing south road
Taizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
Wuxi Innopal International Trade CO.,LTD
Contact:+86-510-80711901-8003
Address:Room 402,Building 5,Longze Garden,No.17,South huanjiu Road,Yixing City, Jiangsu,China
Shanghai Balmxy Pharmaceutical Co., Ltd
Contact:0086-21-24206007
Address:Room 402, 15#, No. 909 wangyue Road, shanghai, P. R. China
Doi:10.1016/S0040-4020(97)10046-1
(1997)Doi:10.1007/BF00601117
()Doi:10.1002/jhet.5570340541
(1997)Doi:10.1021/om9707026
(1997)Doi:10.1016/S0040-4039(97)10283-0
(1997)Doi:10.1016/S0022-328X(99)00029-7
(1999)
